Search Result "T-cell lymphomas"
New Targets of Therapy in T-Cell Lymphomas
Journal: Current Drug Targets
Volume: 11 Issue: 4 Year: 2010 Page: 482-493
Author(s): Jack Erter, Lapo Alinari, Kamruz Darabi, Metin Gurcan, Ramiro Garzon, Guido Marcucci, Mark A. Bechtel, Henry Wong, Pierluigi Porcu
Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 3 Year: 2018 Page: 308-340
Author(s): Kamel Laribi,Mustapha Alani,Catherine Truong,Alix Baugier de Materre
Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 1 Year: 2011 Page: 70-93
Author(s): Ewa Lech-Maranda, Ewa Robak, Tadeusz Robak
Immunological Aspects of Adult T-Cell Leukemia/Lymphoma (ATLL), a Possible Neoplasm of Regulatory T-Cells
Journal: Current Immunology Reviews
Volume: 4 Issue: 4 Year: 2008 Page: 242-250
Author(s): Yasuaki Yamada, Shimeru Kamihira
Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
Journal: Current Drug Targets
Volume: 10 Issue: 2 Year: 2009 Page: 104-109
Author(s): A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville, J. H. Woo
Physiopathogenesis of Lymphoma
Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Edgar Gil Rizzatti
Doi: 10.2174/978160805259211201010151
Molecular Cloning of a Novel PPEF-1 Gene Variant from a T-Cell Lymphoblastic Lymphoma Cell Line
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 6 Issue: 1 Year: 2012 Page: 72-77
Author(s): Ping Ho, Ken-Shwo Dai, Hui-Ling Chen
The Life Cycle of Cutaneous T Cell Lymphoma Reveals Opportunities for Targeted Drug Therapy
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 7 Year: 2004 Page: 609-619
Author(s): Carole L Berger, Richard Edelson
Notch Signaling in Leukemias and Lymphomas
Journal: Current Molecular Medicine
Volume: 8 Issue: 1 Year: 2008 Page: 51-59
Author(s): Franziska Jundt, Rolf Schwarzer, Bernd Dorken
Treatment of Refractory p53 Mutation Large B-cell Lymphoma with Daratumumab and Venetoclax Followed by CAR-T Cell Therapy: Case Report and Animal Study
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 0 Year: 2024 Page: 1-7
Author(s):